Lobbying activity
Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 1,778 filings
Q3
RUBICON ADVISORS, LLC for DR. REDDY'S LABORATORIES, LTD
Q3
RUBICON ADVISORS, LLC for DYNAVAX TECHNOLOGIES
Q3
TODD STRATEGY GROUP for MILLIPORESIGMA
Q3
TODD STRATEGY GROUP for KALEO
Q3
TALLEY STRATEGIES LLC for TEVA PHARMACEUTICALS USA, INC.
Q3
TODD STRATEGY GROUP for EMD SERONO INC.
Q3
ALNYLAM PHARMACEUTICALS, INC. for ALNYLAM PHARMACEUTICALS, INC.
Q3
NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD) for NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)
Q3
THE METROHEALTH SYSTEM for THE METROHEALTH SYSTEM
Q3
NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC for MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMER
Q3
B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF TAKEDA PHARMACEUTICALS AMERICA, INC.
Q3
ALSTON & BIRD LLP for TRAVERE THERAPEUTICS
Q3
B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF PHLOW CORPORATION
Q3
B HALL STRATEGIES, LLC for TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF PHRMA
Q3
B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF ORGANON, LLC
Q3
B HALL STRATEGIES, LLC for TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF NOVARTIS
Q3
B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF MERCK & CO., INC.
Q3
B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF GILEAD SCIENCES, INC.
Q3
B HALL STRATEGIES, LLC for TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GENENTECH, INC.
Q3
B HALL STRATEGIES, LLC for TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF ELI LILLY AND COMPANY
Q3
B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF DAIICHI SANKYO, INC.
Q3
B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF BEONE MEDICINES USA, INC.
Q3
B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF ASTELLAS PHARMA US, INC.
Q3
B HALL STRATEGIES, LLC for TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF AMGEN, INC.
Q3
FORWARD GLOBAL for QUOIN PHARMACEUTICALS, INC.